Celestial Biolabs Ltd. announced unaudited earnings results for the second quarter and six months ended September 30, 2015. For the quarter, the company reported sales/income from operations of INR 84.914 million compared to INR 74.666 million reported a year ago. Profit from operations before other income, finance costs and exceptional items was INR 10.141 million compared to INR 8.28 million reported a year ago. Profit from ordinary activities before tax was INR 5.387 million compared to INR 4.023 million reported a year ago. Net profit was INR 4.390 million or INR 0.24 per basic and diluted share before and after extraordinary items compared to INR 3.279 million or INR 0.19 per basic and diluted share before and after extraordinary items reported a year ago.

For the six months, the company reported sales/income from operations of INR 165.175 million compared to INR 146.071 million reported a year ago. Profit from operations before other income, finance costs and exceptional items was INR 19.734 million compared to INR 16.149 million reported a year ago. Profit from ordinary activities before tax was INR 10.093 million compared to INR 7.635 million reported a year ago. Net profit was INR 8.225 million or INR 0.44 per basic and diluted share before and after extraordinary items compared to INR 6.223 million or INR 0.36 per basic and diluted share before and after extraordinary items reported a year ago.